phase readout
saveNCT06657885: CAbotégravir LENacapavir DUal Long Acting
WITHDRAWNupdated 1mo ago
community read0 votes
Sponsor: Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba. Phase: PHASE2. Conditions: HIV1 Infection, Multi-treated Patients Who Have Received Multiple Lines of Antiretroviral Treatment, CABOTEGRAVIR, LENACAPAVIR, Stable Oral Antiretroviral Treatment for at Least 6 Months
view source ↗
comments(0)
5-min edit window · permanent after that